Gaithersburg, MD, and Vancouver, Canada – Sirnaomics Inc. (Sirnaomics) and Precision NanoSystems Inc. (PNI) jointly announced a partnership on the

Agena Bioscience, a global provider of low cost and high-throughput molecular testing solutions, today announced the launch of the iPLEX®

MOUNTAIN VIEW, California, June 2, 2020  – Specific Diagnostics today announces that the National Institute for Allergy and Infectious Disease

– CanSinoBIO will license in Precision NanoSystems’ proprietary RNA vaccine platform technology – Precision NanoSystems will lead RNA vaccine formulation

Additional Resources Will Support Product Development and Expansion of Manufacturing Capabilities   Sacramento, Calif.—(May 19, 2020)—Nivagen Pharmaceuticals, Inc. (“Nivagen”), a

MADISON, WI–Nimble Therapeutics, Inc. today announced a collaboration with Roche Diagnostics to accelerate discovery of novel peptide-based molecules for the

MADISON, WI, USA and Malmö, SE — Nimble Therapeutics and Svar Life Science today announced a collaboration to discover, develop,

Vancouver BC, April 8, 2020 Precision NanoSystems (PNI), a global leader in enabling transformative nanomedicines today announced the appointment of

Funded by the Bill and Melinda Gates Foundation, CoVIC Seeks to Find Therapeutic Candidates for COVID-19 in Just Weeks Salt

Dynex’s portfolio of open, automated microplate instruments, with a global distribution network and footprint, demonstrates ability to support COVID-19 testing